-
Segelov, E, Thavaneswaran, S, Waring, PM, Desai, J, Robledo, KP, Gebski, VJ, Elez, E, Nott, LM, Karapetis, CS, Lunke, S, et al.
Response to Cetuximab With or Without Irinotecan in Patients With Refractory Metastatic Colorectal Cancer Harboring the KRAS G13D Mutation: Australasian Gastro-Intestinal Trials Group ICECREAM Study..
J Clin Oncol
34(19)
:
2258 -2264
2016
view publication
-
Kondrashova, O, Lunke, S, Mileshkin, L, Alsop, K, Scott, C, Hamilton, A, Ananda, S, Quinn, M, Bowtell, D, McNally, O, et al.
2773 ALLOCATE: sorting ovarian cancer patients into treatment categories based on genetic characteristics of their tumours.
European Journal of Cancer
51:
s555
2015
view publication
-
Rafehi, H, Balcerczyk, A, Lunke, S, Kaspi, A, Ziemann, M, Harikrishnan, KN, Okabe, J, Khurana, I, Ooi, J, Khan, AW, et al.
Regulation of inflammatory gene expression by histone acetylation and HDAC inhibition in human aortic endothelial cells.
Atherosclerosis
241(1)
:
e6
2015
view publication
-
Hsu, AL, Kondrashova, O, Lunke, S, Love, CJ, Meldrum, C, Marquis-Nicholson, R, Corboy, G, Pham, K, Wakefield, M, Waring, PM, et al.
AmpliVar: mutation detection in high-throughput sequence from amplicon-based libraries..
Hum Mutat
36(4)
:
411 -418
2015
view publication
-
Hong, MKH, Macintyre, G, Wedge, DC, Van Loo, P, Patel, K, Lunke, S, Alexandrov, LB, Sloggett, C, Cmero, M, Marass, F, et al.
Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer..
Nat Commun
6:
6605
2015
view publication